FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2741528982> ?p ?o ?g. }

• W2741528982 endingPage "e474" @default.
• W2741528982 startingPage "e465" @default.
• W2741528982 abstract "BackgroundEarly HIV diagnosis reduces morbidity, mortality, the probability of onward transmission, and their associated costs, but might increase cost because of earlier initiation of antiretroviral treatment (ART). We investigated this trade-off by estimating the cost-effectiveness of HIV screening in primary care.MethodsWe modelled the effect of the four-times higher diagnosis rate observed in the intervention arm of the RHIVA2 randomised controlled trial done in Hackney, London (UK), a borough with high HIV prevalence (≥0·2% adult prevalence). We constructed a dynamic, compartmental model representing incidence of infection and the effect of screening for HIV in general practices in Hackney. We assessed cost-effectiveness of the RHIVA2 trial by fitting model diagnosis rates to the trial data, parameterising with epidemiological and behavioural data from the literature when required, using trial testing costs and projecting future costs of treatment.FindingsOver a 40 year time horizon, incremental cost-effectiveness ratios were £22 201 (95% credible interval 12 662–132 452) per quality-adjusted life-year (QALY) gained, £372 207 (268 162–1 903 385) per death averted, and £628 874 (434 902–4 740 724) per HIV transmission averted. Under this model scenario, with UK cost data, RHIVA2 would reach the upper National Institute for Health and Care Excellence cost-effectiveness threshold (about £30 000 per QALY gained) after 33 years. Scenarios using cost data from Canada (which indicate prolonged and even higher health-care costs for patients diagnosed late) suggest this threshold could be reached in as little as 13 years.InterpretationScreening for HIV in primary care has important public health benefits as well as clinical benefits. We predict it to be cost-effective in the UK in the medium term. However, this intervention might be cost-effective far sooner, and even cost-saving, in settings where long-term health-care costs of late-diagnosed patients in high-prevalence regions are much higher (≥60%) than those of patients diagnosed earlier. Screening for HIV in primary care is cost-effective and should be promoted.FundingNHS City and Hackney, UK Department of Health, National Institute for Health Research Collaboration for Leadership in Applied Health Research and Care." @default.
• W2741528982 created "2017-08-08" @default.
• W2741528982 creator A5005689730 @default.
• W2741528982 creator A5016768242 @default.
• W2741528982 creator A5027937855 @default.
• W2741528982 creator A5034036124 @default.
• W2741528982 creator A5039854648 @default.
• W2741528982 creator A5041624935 @default.
• W2741528982 creator A5047135185 @default.
• W2741528982 creator A5052935817 @default.
• W2741528982 creator A5055207340 @default.
• W2741528982 creator A5070158322 @default.
• W2741528982 creator A5079520595 @default.
• W2741528982 creator A5088969037 @default.
• W2741528982 date "2017-10-01" @default.
• W2741528982 modified "2023-10-17" @default.
• W2741528982 title "Cost-effectiveness of screening for HIV in primary care: a health economics modelling analysis" @default.
• W2741528982 cites W1413161224 @default.
• W2741528982 cites W1554940778 @default.
• W2741528982 cites W1982259868 @default.
• W2741528982 cites W1990058613 @default.
• W2741528982 cites W2008110646 @default.
• W2741528982 cites W2027951678 @default.
• W2741528982 cites W2040595978 @default.
• W2741528982 cites W2064983055 @default.
• W2741528982 cites W2097128175 @default.
• W2741528982 cites W2099854520 @default.
• W2741528982 cites W2106854762 @default.
• W2741528982 cites W2151969385 @default.
• W2741528982 cites W2152505869 @default.
• W2741528982 cites W2171966089 @default.
• W2741528982 cites W2173587025 @default.
• W2741528982 cites W2174951518 @default.
• W2741528982 cites W2178166689 @default.
• W2741528982 cites W2179099212 @default.
• W2741528982 cites W2184589485 @default.
• W2741528982 cites W2238552371 @default.
• W2741528982 cites W2403671454 @default.
• W2741528982 cites W2512045947 @default.
• W2741528982 cites W4301436959 @default.
• W2741528982 doi "https://doi.org/10.1016/s2352-3018(17)30123-6" @default.
• W2741528982 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/5614770" @default.
• W2741528982 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/28768604" @default.
• W2741528982 hasPublicationYear "2017" @default.
• W2741528982 type Work @default.
• W2741528982 sameAs 2741528982 @default.
• W2741528982 citedByCount "43" @default.
• W2741528982 countsByYear W27415289822017 @default.
• W2741528982 countsByYear W27415289822018 @default.
• W2741528982 countsByYear W27415289822019 @default.
• W2741528982 countsByYear W27415289822020 @default.
• W2741528982 countsByYear W27415289822021 @default.
• W2741528982 countsByYear W27415289822022 @default.
• W2741528982 crossrefType "journal-article" @default.
• W2741528982 hasAuthorship W2741528982A5005689730 @default.
• W2741528982 hasAuthorship W2741528982A5016768242 @default.
• W2741528982 hasAuthorship W2741528982A5027937855 @default.
• W2741528982 hasAuthorship W2741528982A5034036124 @default.
• W2741528982 hasAuthorship W2741528982A5039854648 @default.
• W2741528982 hasAuthorship W2741528982A5041624935 @default.
• W2741528982 hasAuthorship W2741528982A5047135185 @default.
• W2741528982 hasAuthorship W2741528982A5052935817 @default.
• W2741528982 hasAuthorship W2741528982A5055207340 @default.
• W2741528982 hasAuthorship W2741528982A5070158322 @default.
• W2741528982 hasAuthorship W2741528982A5079520595 @default.
• W2741528982 hasAuthorship W2741528982A5088969037 @default.
• W2741528982 hasBestOaLocation W27415289821 @default.
• W2741528982 hasConcept C107130276 @default.
• W2741528982 hasConcept C112930515 @default.
• W2741528982 hasConcept C120665830 @default.
• W2741528982 hasConcept C121332964 @default.
• W2741528982 hasConcept C126322002 @default.
• W2741528982 hasConcept C127454912 @default.
• W2741528982 hasConcept C138816342 @default.
• W2741528982 hasConcept C144024400 @default.
• W2741528982 hasConcept C149923435 @default.
• W2741528982 hasConcept C15716912 @default.
• W2741528982 hasConcept C159110408 @default.
• W2741528982 hasConcept C160735492 @default.
• W2741528982 hasConcept C162324750 @default.
• W2741528982 hasConcept C167704817 @default.
• W2741528982 hasConcept C187736073 @default.
• W2741528982 hasConcept C18903297 @default.
• W2741528982 hasConcept C194828623 @default.
• W2741528982 hasConcept C2908647359 @default.
• W2741528982 hasConcept C3019080777 @default.
• W2741528982 hasConcept C44249647 @default.
• W2741528982 hasConcept C50522688 @default.
• W2741528982 hasConcept C524218345 @default.
• W2741528982 hasConcept C61511704 @default.
• W2741528982 hasConcept C64332521 @default.
• W2741528982 hasConcept C71924100 @default.
• W2741528982 hasConcept C86803240 @default.
• W2741528982 hasConcept C99454951 @default.
• W2741528982 hasConceptScore W2741528982C107130276 @default.
• W2741528982 hasConceptScore W2741528982C112930515 @default.
• W2741528982 hasConceptScore W2741528982C120665830 @default.
• W2741528982 hasConceptScore W2741528982C121332964 @default.

• next